# Predicting Immunotherapy Response and Survival of Lung Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Lung)

> **NCT07059923** · — · RECRUITING · sponsor: **Union Hospital, Tongji Medical College, Huazhong University of Science and Technology** · enrollment: 400 (estimated)

## Conditions studied

- Lung Cancer (Diagnosis)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07059923
- **Lead sponsor:** Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2025-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07059923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07059923, "Predicting Immunotherapy Response and Survival of Lung Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Lung)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07059923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*